Chronic Lymphocytic Leukemia
Showing NaN - NaN of 41
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)
Recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib
- +3 more
-
Fountain Valley, California
- +201 more
Jan 16, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Bendamustine, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Los Angeles, California
- +142 more
Jan 10, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +3 more
-
Boston, Massachusetts
- +11 more
Nov 23, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Venetoclax)
Completed
- Chronic Lymphocytic Leukemia
-
Louisville, Kentucky
- +66 more
Nov 9, 2022
Chronic Lymphocytic Leukemia, Hypogammaglobulinemia Trial in Worldwide (Panzyga, Placebo)
Recruiting
- Chronic Lymphocytic Leukemia
- Hypogammaglobulinemia
- Panzyga
- Placebo
-
Saint Petersburg, Florida
- +52 more
Aug 10, 2022
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in Worldwide (KRT-232, acalabrutinib)
Recruiting
- Diffuse Large B Cell Lymphoma
- +2 more
-
Goshen, Indiana
- +44 more
Aug 3, 2022
Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))
Recruiting
- Multiple Myeloma
- +13 more
- RITA (App)
-
Milano, ItalyASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Pirtobrutinib, Venetoclax, Rituximab)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Pirtobrutinib
- +2 more
-
Phoenix, Arizona
- +116 more
Jun 27, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Acalabrutinib (ACP-196)
- +3 more
-
Chandler, Arizona
- +156 more
Jun 2, 2022
Chronic Lymphocytic Leukemia Treated With Idelalisib and
Completed
- Chronic Lymphocytic Leukemia
- idelalisib and rituximab
-
Cona, Ferrara, Italy
- +37 more
May 11, 2022
Hepatitis B Reactivations in Patients Affected by Chronic
Completed
- Chronic Lymphocytic Leukemia
- Lamivudine
- No prophylaxis
-
Cona, Ferrara, Italy
- +22 more
May 11, 2022
Chronic Lymphocytic Leukemia Trial in Milano (Venetoclax, Imbruvica Oral Product)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Venetoclax
- Imbruvica Oral Product
-
Milano, MI, ItalyOspedale San Raffaele
Apr 2, 2022
Chronic Lymphocytic Leukemia Trial in Milano (Ibrutinib and obinutuzumab)
Recruiting
- Chronic Lymphocytic Leukemia
- Ibrutinib and obinutuzumab
-
Milano, MI, ItalyStrategic Research Program on CLL
Apr 2, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)
Enrolling by invitation
- Chronic Lymphocytic Leukemia
- +6 more
-
Duarte, California
- +165 more
Mar 24, 2022
Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Chandler, Arizona
- +107 more
Mar 8, 2022
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Duvelisib, Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
La Jolla, California
- +91 more
Dec 14, 2021
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Alessandria, Italy
- +17 more
Jan 3, 2022
Relapsed or Refractory Chronic Lymphocytic Leukemia
Recruiting
- Chronic Lymphocytic Leukemia
- +2 more
-
Cona, Ferrara, Italy
- +26 more
Jan 3, 2022
CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)
Recruiting
- CLL
- Chronic Lymphocytic Leukemia
- Peripheral blood samples withdrawal
-
Milano, Italy
- +1 more
Jan 3, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- +2 more
- Tafasitamab
- +2 more
-
Jacksonville, Florida
- +16 more
Dec 10, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
Non-Hodgkin Lymphoma, Burkitt's Lymphoma, Chronic Lymphocytic Leukemia Trial in Italy, United Kingdom, United States (ADCT-402)
Completed
- Non-Hodgkin Lymphoma
- +8 more
-
La Jolla, California
- +10 more
Apr 27, 2021